Default company panoramic image
Logo

CanDiag, Inc.

CanDiag is pursuing development and commercialization of a blood test to accurately detect cancer and reduce unnecessary breast biopsies.

  • Stage Concept Only
  • Industry Biotechnology
  • Location Charlotte, NC, USA
  • Currency USD
  • Website candiaginc.com

Company Summary

CanDiag, Inc., a UNC Charlotte spin-out, has developed a patented antibody based blood test to diagnose breast cancer. In a study involving women with suspicious mammograms, CanDiag's test identified invasive breast cancer with 100% sensitivity. Our mission is to initially offer diagnostics for breast cancer. Our vision is to offer products ranging from accurate cancer screening and imaging tests to targeted drug delivery therapies.

Team

  • Default avatar
    Pinku Mukherjee
    CEO, Co-Founder

  • Default avatar
    Rahul Puri
    Co-Founder, Director

  • Default avatar
    Taffy Williams
    Director

  • Default avatar
    Susan Alpert
    Regulatory Consultant

  • Default avatar
    Herbert Kim Lyerly
    Scientific Advisor

  • Default avatar
    Myla Lai-Goldman
    Scientific Advisor